181 related articles for article (PubMed ID: 19924575)
1. Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression.
Park Y; Kang MH; Seo HY; Park JM; Choi CW; Kim YH; Kim IS; Kim JS; Oh SC
Med Oncol; 2010 Dec; 27(4):1192-9. PubMed ID: 19924575
[TBL] [Abstract][Full Text] [Related]
2. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
3. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.
Luo D; Huang H; Lu ML; Zhao GF; Chang J; Zheng MY; Wang Y
Pathol Oncol Res; 2012 Apr; 18(2):491-7. PubMed ID: 22109561
[TBL] [Abstract][Full Text] [Related]
4. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
[TBL] [Abstract][Full Text] [Related]
5. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.
Hu X; Xin Y; Xiao Y; Zhao J
Pathol Oncol Res; 2014 Oct; 20(4):805-11. PubMed ID: 24643316
[TBL] [Abstract][Full Text] [Related]
7. The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patients.
Choi YJ; Kim ST; Park KH; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
Med Oncol; 2012 Jun; 29(2):582-8. PubMed ID: 21327739
[TBL] [Abstract][Full Text] [Related]
8. Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection.
Kang HJ; Kim DH; Jeon TY; Lee SH; Shin N; Chae SH; Kim GH; Song GA; Kim DH; Srivastava A; Park DY; Lauwers GY
Gastrointest Endosc; 2010 Sep; 72(3):508-15. PubMed ID: 20554277
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
[TBL] [Abstract][Full Text] [Related]
10. CXCL5 overexpression is associated with late stage gastric cancer.
Park JY; Park KH; Bang S; Kim MH; Lee JE; Gang J; Koh SS; Song SY
J Cancer Res Clin Oncol; 2007 Nov; 133(11):835-40. PubMed ID: 17479287
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of CD147 and E-cadherin in human gastric carcinoma].
Wang LL; Yao GY; Zhang BY; Zhang XM; Zhao M
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):515-9. PubMed ID: 19950699
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features of submucosal carcinoma of the stomach.
Hanazaki K; Wakabayashi M; Sodeyama H; Miyazawa M; Yokoyama S; Sode Y; Kawamura N; Miyazaki T; Ohtsuka M
J Clin Gastroenterol; 1997 Apr; 24(3):150-5. PubMed ID: 9179733
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
14. Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer.
Kim BS; Oh ST; Yook JH; Kim BS
Surgery; 2014 Jun; 155(6):1030-5. PubMed ID: 24792508
[TBL] [Abstract][Full Text] [Related]
15. Intramucosal gastric cancer: the rate of lymph node metastasis in signet ring cell carcinoma is as low as that in well-differentiated adenocarcinoma.
Lee SH; Jee SR; Kim JH; Seol SY
Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):170-4. PubMed ID: 25503738
[TBL] [Abstract][Full Text] [Related]
16. p53 overexpression and proliferative activity do not correlate with lymph node metastasis in early gastric cancer.
Kanai T; Konno H; Maruyama K; Baba M; Tanaka T; Maruo Y; Nishino N; Nakamura S; Baba S; Sugimura H
Eur Surg Res; 1997; 29(1):35-41. PubMed ID: 9013104
[TBL] [Abstract][Full Text] [Related]
17. Is it reasonable to treat early gastric cancer with signet ring cell histology by endoscopic resection? Analysis of factors related to lymph-node metastasis.
Park JM; Kim SW; Nam KW; Cho YK; Lee IS; Choi MG; Chung IS; Song KY; Park CH; Jung CK
Eur J Gastroenterol Hepatol; 2009 Oct; 21(10):1132-5. PubMed ID: 19369881
[TBL] [Abstract][Full Text] [Related]
18. The relationship of prognosis to surgery and pathologic characteristics of stage IV (M0) gastric cancer patients.
Xue YW; Wei YZ
Chin J Cancer; 2010 Apr; 29(4):355-8. PubMed ID: 20346207
[TBL] [Abstract][Full Text] [Related]
19. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma.
Lin T; Ding YQ; Li JM
Med Oncol; 2012 Jun; 29(2):878-85. PubMed ID: 21336986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
